1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
63CE5133837C1064F85256EF900706B05
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/feb-2003-gbc-presentation-portfolio-driven-ma-in-pharma-pharmacia?opendocument
18
19opendocument
20107.23.176.162
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25RAS




Products & Services R and AS Conferences 2003 Feb 2003: Portfolio Optimization

Feb 2003 GBC Presentation: Portfolio-driven M&A in Pharma (Pharmacia)

ID: GBC-P022003PNP


Published: Pre-2013


Delivery Format: PowerPoint


 

close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.


Buy Now

Direct access to this research is not included with your membership level.

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • PRESENTER INFO
The presentation reviews major legislation passed by Congress related to the Pharmaceutical Industry and reviews how it impacted industry dynamics resulting in the current wave of acquisitions. The presentation then proceeds to examine which companies are likely candidates for further consolidation in the near term.

Industries Profiled:
Pharmaceutical


Companies Profiled:
Pharmacia

Neil Mahoney
Vice President of Global Competitive Intelligence

Pharmacia